Search Results for "Pyridostigmine For Constipation"
Original Source: Use of Pyridostigmine for Constipation in Diabetics
Doctors at Mayo Clinic are doing this study to learn if pyridostigmine, a drug, affects the speed at which food travels through the stomach, intestines and colon, and if pyridostigmine improves constipation symptoms in patients with diabetes. Pyridostigmine has been approved by the Food and Drug Administration (FDA) for routine clinical use, however, its use as proposed in this study is considered investigational.
Matching Channels
Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...
Matching News
Linzess (linaclotide), a medication for irritable bowel syndrome (IBS) with constipation or chronic idiopathic constipation is now available in American pharmacies, Ironwood Pharmaceuticals Inc. and F...
New Option for Constipation: FDA Approves Linaclotide
The once-daily drug shows efficacy over placebo in reducing both chronic constipation and constipation associated with irritable bowel syndrome. FDA Approvals
Constipation drug may bring US patients relief
The US Food and Drug Administration has approved linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.
Linzess (Linaclotide) Approved For IBS And Constipation, And Chronic Idiopathic Constipation
Linzess (linaclotide), for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation, has been approved by the Food and Drug Administration (FDA), USA. The approv...
UPDATE 1-US FDA approves Ironwood constipation drug
Aug 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Ironwood Pharmaceuticals Inc's drug to treat chronic constipation and irritable bowel syndrome with constipation in adults...
FDA approves Ironwood constipation drug
(Reuters) - The U.S. Food and Drug Administration on Thursday approved Ironwood Pharmaceuticals Inc's drug to treat chronic constipation and irritable bowel syndrome with constipation in adults.
Sucampo says constipation drug approved in UK
Sucampo Pharmaceuticals Inc. said Wednesday that U.K. regulators approved its constipation drug Amitiza.Sucampo said the drug is approved to treat chronic constipation that is not caused by other dis...
Constipation Treatments Not Equally Effective: Review
MONDAY, Jan. 28 -- Some treatments are more effective than others for relieving constipation in seniors, according to a new review. And laxatives aren't always enough, researchers say. Constipation is...
Matching PubMed Articles
The simultaneous use of the repellent DEET, pyridostigmine, and organophosphorus pesticides has been assumed as a potential cause for the Gulf War Illness and combinations have been tested in differen...
PURPOSE: This study aimed to evaluate the bowel habit and laxative use in advanced cancer patients with constipation in palliative care unit. METHODS: It was a cross-sectional study using a self-desig...
New drugs for the treatment of constipation.
This review introduces new therapeutic options in the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. Therefore, prucalopride and lubiprostone are discusse...
Guidelines for the Treatment of Constipation.
While constipation is a common symptom in Korea, there are no existing treatment guidelines. Although constipation may occur as a result of organic cause, there is no obstructive mucosal or structural...
Orthostatic hypotension affects patients with autonomic failure producing considerable disability because of presyncopal symptoms. Severely affected patients may have residual sympathetic tone that ca...
